The management of condyloma acuminata in the pediatric population.
Culton
Donna A
DA
Department of Dermatology, University of North Carolina at Chapel Hill, NC 27599, USA. DCulton@unch.unc.edu
Morrell
Dean S
DS
Burkhart
Craig N
CN
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D052685:Alphapapillomavirus; D000634:Aminoquinolines / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D000077404:Cidofovir; D002927:Cimetidine / Q000627:therapeutic use; D003218:Condylomata Acuminata / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy* / Q000821:virology; D017679:Cryotherapy; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D062109:Dermatologic Surgical Procedures; D005260:Female; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D000077271:Imiquimod; D007641:Keratolytic Agents / Q000627:therapeutic use; D053685:Laser Therapy / Q000379:methods; D054025:Lasers, Dye / Q000627:therapeutic use; D054020:Lasers, Gas / Q000627:therapeutic use; D008297:Male; D063065:Organophosphonates / Q000627:therapeutic use; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy* / Q000635:transmission; D011034:Podophyllotoxin / Q000627:therapeutic use; D012867:Skin / Q000821:virology; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000998:Antiviral Agents; D006635:Histamine H2 Antagonists; D007641:Keratolytic Agents; D063065:Organophosphonates; D002927:Cimetidine; D003596:Cytosine; D000077404:Cidofovir; D011034:Podophyllotoxin; D000077271:Imiquimod